
PHERGAIN
OFFICIAL TITLE: CHEMOTHERAPY-FREE TRASTUZUMAB AND PERTUZUMAB IN HER2-POSITIVE (HUMAN EPIDERMAL RECEPTOR) BREAST CANCER: FDG-PET RESPONSE-ADAPTED STRATEGY. THE PHERGAIN STUDY

CLINICAL TRIAL DETAILS
THE STUDY ASSESS THE EARLY METABOLIC EFFECTS OF NEOADJUVANT TREATMENT WITH TRASTUZUMAB AND PERTUZUMAB (± ENDOCRINE THERAPY) ON THE PRIMARY TUMOR AND AXILLARY LYMPH NODES AND THEIR PREDICTIVE VALUE FOR PATHOLOGIC COMPLETE RESPONSE (PCR) IN THE BREAST AND AXILLA.
AND ALSO ASSESS 3-YEAR INVASIVE DISEASE-FREE SURVIVAL (IDFS) IN PATIENTS WITH HER2-POSITIVE (HER: HUMAN EPIDERMAL RECEPTOR) BREAST CANCER TREATED WITH NEOADJUVANT TRASTUZUMAB AND PERTUZUMAB (± ENDOCRINE THERAPY) USING A FDG-PET RESPONSE-ADAPTED STRATEGY.
​
​
PHERGAIN AT CLINICALTRIALS.GOV
TUMOR TYPE
PHASE
HER2+ EBC
II
377
56
Spain, Portugal, France, UK, Italia, Belgium, Germany
N
SITES
COUNTRY
STATUS
Analysis
PRESS RELEASE

SCIENTIFIC IMPACT

ASCO 2023 – DOWNLOAD THE PRESENTATION
ASCO 2023 – DOWNLOAD THE LAY LANGUAGE SUMMARY
PHERGAIN CASE STUDY 2023 – DOWNLOAD
ESMO BREAST 2022 – DOWNLOAD THE SLIDES
SABCS 2017 – DOWNLOAD THE POSTER
Dr. Javier Cortés and Dr. Antonio Llombart
Dr. Vanesa Quiroga
BLOG ARTICLES RELATED

PHERGAIN SITES

SPAIN
Hospital Universitari Vall D'Hebron
SPAIN
Institut Català d' Oncologia L'Hospitalet (ICO)
SPAIN
Hospital Clínic i Provincial de Barcelona
SPAIN
Institut Català d' Oncologia Badalona (ICO)
SPAIN
Hospital Universitario La Paz
SPAIN
Hospital Universitario Virgen del Rocío
SPAIN
Hospital Universitario Reina Sofía
SPAIN
Hospital Universitario Virgen de la Victoria
SPAIN
Complejo Hospitalario de Jaén
SPAIN
Hospital Clínico Universitario de Valencia
SPAIN
Consorci Hospital General Universitari de València
SPAIN
Hospital Universitari i Politècnic La Fe
SPAIN
Instituto Valenciano de Oncología (IVO)
SPAIN
Hospital Provincial de Castellón
SPAIN
Complejo Hospitalario Universitario A Coruña (CHUAC)
SPAIN
Complejo Hospitalario Universitario de Santiago (CHUS)
SPAIN
Hospital Universitario de Burgos
SPAIN
Hospital Universitario Miguel Servet
SPAIN
Hospital Arnau de Vilanova de Valencia
SPAIN
Hospital Universitario Ramón y Cajal
SPAIN
Institut Català d' Oncologia Girona (ICO)
SPAIN
Hospital Universitari Sant Joan de Reus
SPAIN
Hospital Universitario Arnau de Vilanova de Lleida
SPAIN
Hospital Universitario Dr. Peset
SPAIN
Hospital Clínico Universitario Lozano Blesa
FRANCE
Hôpital Tenon AP-HP
FRANCE
Hopital Europeen Georges Pompidou
FRANCE
Institut Universitaire du Cancer Toulouse, Toulouse
FRANCE
Centre Paul Strauss
FRANCE
Groupe Hospitalier Diaconesses
FRANCE
CLCC d'Auvergne. Centre Jean Perrin. Clermont Ferrand
FRANCE
Institute de Cancerologie de Lorraine, Nancy
ITALY
Ospedale Antonio Perrino
ITALY
Ospedale San Gerardo
ITALY
Instituto Europeo di Oncologia
ITALY
Istituti Ospitalieri Cremona
ITALY
Ospedale Guglielmo da Saliceto
ITALY
Ospedale S.Orsola Bologna
ITALY
Ospedale Mantova
UK
Barts Cancer Institute
UK
The Christie NHS Foundation Trust
UK
Royal Cornwall Hospital NHS Trust
GERMANY
National Center for Tumor Disease (NCT)
GERMANY
Hämatologisch-Onkologische Schwerpunktpraxis
GERMANY
Kliniken Essen Mitte
GERMANY
Klinikum Rechts der Isar
GERMANY
Klinikum der Med. Fakultät Halle
GERMANY
Städtisches Klinikum „St. Georg“ Leipzig
BELGIUM
Institut Jules Bordet
PORTUGAL
Hospital Da Luz Lisboa
PORTUGAL
Breast Cancer Unit of Centro Hospitalar São João
PORTUGAL
Hospital Senhora da Oliveira Guimarães
PORTUGAL
Hospital Fernando da Fonseca
PORTUGAL
Centro Hospitalar de Trás-os-Montes e Alto Douro
PORTUGAL
Hospital Beatriz Ângelo
PORTUGAL
Hospital do Santo Antonio